The IPO of 60 Degrees Pharmaceuticals, Inc (NASDAQ:SXTP) is expected to have a neutral short-term impact on the stock price. The offering price range is between $4.30 and $6.30 per share, and the insider lock-up period of 180 days may limit any significant price fluctuations in the short term. However, the company's growth-oriented focus on infectious disease therapies may attract investor interest.